Biochemical Pharmacology

Article	Citations
The growth of siRNA-based therapeutics: Updated clinical studies	300
Detection of Viral Infections by Innate Immunity	250
Sleep timing, chronotype and social jetlag: Impact on cognitive abilities and psychiatric disorders	123
Animal toxins — Nature’s evolutionary-refined toolkit for basic research and drug discovery	115
The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro	108
White adipose tissue dysfunction in obesity and aging	105
Targeting tumor-associated macrophages as an antitumor strategy	104
P2X7 receptor and the NLRP3 inflammasome: Partners in crime	100
Cisplatin in cancer treatment	97
Polo-like kinase 1 (PLK1) signaling in cancer and beyond	96
Therapeutic potential of targeting mitochondrial dynamics in cancer	95
Obesity I: Overview and molecular and biochemical mechanisms	88
Obesity II: Establishing causal links between chemical exposures and obesity	85
Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action	81
Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches	80
Mechanisms of ketamine and its metabolites as antidepressants	79
The relevance of daylight for humans	79
Minocycline promotes functional recovery in ischemic stroke by modulating microglia polarization through STAT1/STAT6 pathways	76
Ferroptosis and its potential as a therapeutic target	73
Recent progress on targeting ferroptosis for cancer therapy	72
Applications and evolution of melittin, the quintessential membrane active peptide	68
Cellular toxicity of the metabolic inhibitor 2-deoxyglucose and associated resistance mechanisms	65
Drug affinity responsive target stability (DARTS) accelerated small molecules target discovery: Principles and application	65
Eg5 targeting agents: From new anti-mitotic based inhibitor discovery to cancer therapy and resistance	64
Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development	63

Oroxylin A reduces osteoclast formation and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation	56
Regulation of IRF3 activation in human antiviral signaling pathways	55
Targeted therapy for breast cancer: An overview of drug classes and outcomes	55
Targeting immunosuppression by TGF-β1 for cancer immunotherapy	55
Antisense drug discovery and development technology considered in a pharmacological context	55
TGF-β1-activated cancer-associated fibroblasts promote breast cancer invasion, metastasis and epithelial-mesenchymal transition by autophagy or overexpression of FAP-α	55
Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics	54
Vitamin D and the risk for cancer: A molecular analysis	54
Molecular pharmacology of P2Y receptor subtypes	53
PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking	53
History of ectonucleotidases and their role in purinergic signaling	53
Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective	52
Amino acid metabolism, transport and signalling in the liver revisited	51
Alzheimer’s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs	51
The inorganic polymer, polyphosphate, blocks binding of SARS-CoV-2 spike protein to ACE2 receptor at physiological concentrations	51
Parathyroid hormone and its related peptides in bone metabolism	50
Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potential	50
Maresin 1 protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting macrophage pyroptosis and inflammatory response	47
Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients	47
Aryl hydrocarbon receptor: Its roles in physiology	47
A nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy	47
Nociceptive signaling mediated by P2X3, P2X4 and P2X7 receptors	47
Insights into the role of GPX3, a highly efficient plasma antioxidant, in cancer	47
Tumor Cells-derived exosomal CircRNAs: Novel cancer drivers, molecular mechanisms, and clinical opportunities	47
Potential role of mitochondria-associated endoplasmic reticulum membrane proteins in diseases	46
N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives	45
Cardiovascular risk factors and molecular routes underlying endothelial dysfunction: Novel opportunities for primary prevention	44
Imperatorin ameliorates mast cell-mediated allergic airway inflammation by inhibiting MRGPRX2 and CamKII/ERK signaling pathway	43
Itaconate attenuates osteoarthritis by inhibiting STING/NF-κB axis in chondrocytes and promoting M2 polarization in macrophages	43
The therapeutic importance of acid-base balance	43
Biogenesis and function of extracellular vesicles in pathophysiological processes of skeletal muscle atrophy	41
Chlorpromazine, an antipsychotic agent, induces G2/M phase arrest and apoptosis via regulation of the PI3K/AKT/mTOR-mediated autophagy pathways in human oral cancer	41
“Selective” serotonin 5-HT2A receptor antagonists	41
Functions of the aryl hydrocarbon receptor (AHR) beyond the canonical AHR/ARNT signaling pathway	41
The voltage-gated potassium channel KV1.3 as a therapeutic target for venom-derived peptides	41
Chrysin induces autophagy-dependent ferroptosis to increase chemosensitivity to gemcitabine by targeting CBR1 in pancreatic cancer cells	41
Snake three-finger α-neurotoxins and nicotinic acetylcholine receptors: molecules, mechanisms and medicine	41
Aryl hydrocarbon receptor (AHR)-mediated inflammation and resolution: Non-genomic and genomic signaling	41
Oxidative stress: Roles in skeletal muscle atrophy	40
Cannabidiol antidepressant-like effect in the lipopolysaccharide model in mice: Modulation of inflammatory pathways	40
Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs	40
ALKBH1 promotes lung cancer by regulating m6A RNA demethylation	39
GLP-1 improves the neuronal supportive ability of astrocytes in Alzheimer’s disease by regulating mitochondrial dysfunction via the cAMP/PKA pathway	39
Snake antivenom: Challenges and alternate approaches	39
Apigenin by targeting hnRNPA2 sensitizes triple-negative breast cancer spheroids to doxorubicin-induced apoptosis and regulates expression of ABCC4 and ABCG2 drug efflux transporters	39
OATP2B1 – The underrated member of the organic anion transporting polypeptide family of drug transporters?	38
AR12 (OSU-03012) suppresses GRP78 expression and inhibits SARS-CoV-2 replication	38
The metabolism and biotransformation of AFB1: Key enzymes and pathways	38
The impact of DAMP-mediated inflammation in severe COVID-19 and related disorders	37
Baicalin promotes hippocampal neurogenesis via the Wnt/β-catenin pathway in a chronic unpredictable mild stress-induced mouse model of depression	37

Targeting mitochondrial respiration for the treatment of acute myeloid leukemia	37
Mesenchymal stem cells derived extracellular vesicles: A promising nanomedicine for drug delivery system	37
Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HT2AR through simultaneous use of β-arrestin 2 and miniGαq bioassays	36
Purinergic signaling in diabetes and metabolism	36
The role of FUNDC1 in mitophagy, mitochondrial dynamics and human diseases	36
Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors	35
B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy	35
Melatonin improves cognitive function by suppressing endoplasmic reticulum stress and promoting synaptic plasticity during chronic cerebral hypoperfusion in rats	35
Angiotensin II receptor type 1 – An update on structure, expression and pathology	35
Rosmarinic acid inhibits oxLDL-induced inflammasome activation under high-glucose conditions through downregulating the p38-FOXO1-TXNIP pathway	35
RSL3 enhances the antitumor effect of cisplatin on prostate cancer cells via causing glycolysis dysfunction	35
The role of clock genes in sleep, stress and memory	35
LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance	34
Non-coding RNAs: Emerging from the discovery to therapeutic applications	34
Human gut bacterial β-glucuronidase inhibition: An emerging approach to manage medication therapy	33
Untangling the web of 5-lipoxygenase-derived products from a molecular and structural perspective: The battle between pro- and anti-inflammatory lipid mediators	33
Dysregulation of iron metabolism in cardiovascular diseases: From iron deficiency to iron overload	33
Short-chain free-fatty acid G protein-coupled receptors in colon cancer	32
The multiple roles and therapeutic potential of HSP60 in cancer	32
Spatial analysis of drug absorption, distribution, metabolism, and toxicology using mass spectrometry imaging	32
Regulation of membrane phospholipid biosynthesis in mammalian cells	32
Upregulation of miR-96-5p by bone marrow mesenchymal stem cells and their exosomes alleviate non-alcoholic steatohepatitis: Emphasis on caspase-2 signaling inhibition	31
Dictamnine, a novel c-Met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K/AKT/mTOR and MAPK signaling pathways	31
Sarsasapogenin restores podocyte autophagy in diabetic nephropathy by targeting GSK3β signaling pathway	31
Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated	31
Future prospects for mitosis-targeted antitumor therapies	31
P2Y receptors for extracellular nucleotides: Contributions to cancer progression and therapeutic implications	31
Ganoderic acid A exerted antidepressant-like action through FXR modulated NLRP3 inflammasome and synaptic activity	31
Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature	30
Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases	30
Targeting the spliceosome machinery: A new therapeutic axis in cancer?	30
Pharmacological inhibition of mitochondrial fission attenuates cardiac ischemia-reperfusion injury in pre-diabetic rats	30
The P2Y/P2X divide: How it began	30
The unfolded protein response as regulator of cancer stemness and differentiation: Mechanisms and implications for cancer therapy	29
Regulation of p53 stability as a therapeutic strategy for cancer	29
The anti-melanogenic effects of ellagic acid through induction of autophagy in melanocytes and suppression of UVA-activated α-MSH pathways via Nrf2 activation in keratinocytes	29
The role of P2Y receptors in regulating immunity and metabolism	29
Acyclovir resistance in herpes simplex viruses: Prevalence and therapeutic alternatives	29
Paracrine TGF-β1 from breast cancer contributes to chemoresistance in cancer associated fibroblasts via upregulation of the p44/42 MAPK signaling pathway	28
Snake venom three-finger toxins and their potential in drug development targeting cardiovascular diseases	28
Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets	28
HDAC3 inhibitor suppresses endothelial-to-mesenchymal transition via modulating inflammatory response in atherosclerosis	28
Diphenyl diselenide alleviates diabetic peripheral neuropathy in rats with streptozotocin-induced diabetes by modulating oxidative stress	28
Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics	28
Necrosulfonamide ameliorates intestinal inflammation via inhibiting GSDMD-medicated pyroptosis and MLKL-mediated necroptosis	28
Dipeptidyl peptidase 4 inhibitors: Applications in innate immunity?	27
The aging brain: sleep, the circadian clock and exercise	27
Mechanism of cystathionine-β-synthase inhibition by disulfiram: The role of bis(N,N-diethyldithiocarbamate)-copper(II)	27
Endothelial and vascular smooth muscle dysfunction in hypertension	27
Fisetin promotes osteoblast differentiation and osteogenesis through GSK-3β phosphorylation at Ser9 and consequent β-catenin activation, inhibiting osteoporosis	27
Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF/MS-based untargeted metabolomics study	27
Protective role of sirtuin3 against oxidative stress and NLRP3 inflammasome in cholesterol accumulation and foam cell formation of macrophages with ox-LDL-stimulation	26
Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis	26
Developmental exposure to phytoestrogens found in soy: New findings and clinical implications	26
Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy	26
Dapagliflozin attenuates arrhythmic vulnerabilities by regulating connexin43 expression via the AMPK pathway in post-infarcted rat hearts	26
Glutamine metabolism in breast cancer and possible therapeutic targets	26
Multi-targeting sodium and calcium channels using venom peptides for the treatment of complex ion channels-related diseases	26
Inhibition of proliferation-linked signaling cascades with atractylenolide I reduces myofibroblastic phenotype and renal fibrosis	26
Berberine exerts anti-tumor activity in diffuse large B-cell lymphoma by modulating c-myc/CD47 axis	26
The amino acid transporter SLC7A11-mediated crosstalk implicated in cancer therapy and the tumor microenvironment	26
Targeting Akt-associated microRNAs for cancer therapeutics	25
Cell adhesion molecule-mediated therapeutic strategies in atherosclerosis: From a biological basis and molecular mechanism to drug delivery nanosystems	25
Adenosine kinase: A key regulator of purinergic physiology	25
Formation of eicosanoids and other oxylipins in human macrophages	25
Roles of microglia in Alzheimer’s disease and impact of new findings on microglial heterogeneity as a target for therapeutic intervention	25
Pathogenic mitochondrial dysfunction and metabolic abnormalities	25
Berberine suppresses bladder cancer cell proliferation by inhibiting JAK1-STAT3 signaling via upregulation of miR-17-5p	25
Role of eicosanoids in liver repair, regeneration and cancer	25
Ceramide de novo synthesis in non-alcoholic fatty liver disease: Pathogenic mechanisms and therapeutic perspectives	25
Biosynthesis and metabolism of endocannabinoids and their congeners from the monoacylglycerol and N-acyl-ethanolamine families	25
m6A modification impacts hepatic drug and lipid metabolism properties by regulating carboxylesterase 2	25
Our evolving understanding of how 27-hydroxycholesterol influences cancer	25
Therapeutics on the clock: Circadian medicine in the treatment of chronic inflammatory diseases	24
Low-activity programming of the PDGFRβ/FAK pathway mediates H-type vessel dysplasia and high susceptibility to osteoporosis in female offspring rats after prenatal dexamethasone exposure	24
Diazepam effects on local cortical neural activity during sleep in mice	24
A novel mechanism underlying alcohol dehydrogenase expression: hsa-miR-148a-3p promotes ADH4 expression via an AGO1-dependent manner in control and ethanol-exposed hepatic cells	24
Activated AMPK mitigates diabetes-related cognitive dysfunction by inhibiting hippocampal ferroptosis	24
S1PR2/RhoA/ROCK1 pathway promotes inflammatory bowel disease by inducing intestinal vascular endothelial barrier damage and M1 macrophage polarization	24
CREB nuclear transcription activity as a targeting factor in the treatment of diabetes and diabetes complications	24

Cathepsin C inhibition as a potential treatment strategy in cancer	24
Orodispersible films – Recent developments and new applications in drug delivery and therapy	24
A comprehensive time course and correlation analysis of indomethacin-induced inflammation, bile acid alterations and dysbiosis in the rat small intestine	24
Protectins: Their biosynthesis, metabolism and structure-functions	24
Resveratrol sensitizes breast cancer to PARP inhibitor, talazoparib through dual inhibition of AKT and autophagy flux	24
S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine	24
MicroRNAs and osteosarcoma: Potential targets for inhibiting metastasis and increasing chemosensitivity	23
Oleoylethanolamide alleviates hyperlipidaemia-mediated vascular calcification via attenuating mitochondrial DNA stress triggered autophagy-dependent ferroptosis by activating PPARα	23
Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets?	23
Exosomes: Powerful weapon for cancer nano-immunoengineering	23
Fangchinoline exerts anticancer effects on colorectal cancer by inducing autophagy via regulation AMPK/mTOR/ULK1 pathway	23
A selective NaV1.1 activator with potential for treatment of Dravet syndrome epilepsy	23
Ischemic stroke and infection: A brief update on mechanisms and potential therapies	23
GSK-3β: An exuberating neuroinflammatory mediator in Parkinson's disease	23
UGT1A1 dysfunction increases liver burden and aggravates hepatocyte damage caused by long-term bilirubin metabolism disorder	23
Sleep during COVID-19 lockdown: A cross-cultural study investigating job system relevance	23
Antimicrobial peptides with symmetric structures against multidrug-resistant bacteria while alleviating antimicrobial resistance	23
NO, CO and H2S: A trinacrium of bioactive gases in the brain	23
Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis	23
Acyl-CoA synthetase-4 mediates radioresistance of breast cancer cells by regulating FOXM1	23
DOCK2 contributes to endotoxemia-induced acute lung injury in mice by activating proinflammatory macrophages	23
A PARP1 PROTAC as a novel strategy against PARP inhibitor resistance via promotion of ferroptosis in p53-positive breast cancer	23
miR-29a-3p-dependent COL3A1 and COL5A1 expression reduction assists sulforaphane to inhibit gastric cancer progression	22
Erianin inhibits the oncogenic properties of hepatocellular carcinoma via inducing DNA damage and aberrant mitosis	22
Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies	22
Metformin in Alzheimer’s disease: An overview of potential mechanisms, preclinical and clinical findings	22
Purinergic signalling in host innate immune defence against intracellular pathogens	22
TTI-101: A competitive inhibitor of STAT3 that spares oxidative phosphorylation and reverses mechanical allodynia in mouse models of neuropathic pain	22
The third-generation EGFR inhibitor almonertinib (HS-10296) resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs	22
Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injury	22
Activation of FXR modulates SOCS3/Jak2/STAT3 signaling axis in a NASH-dependent hepatocellular carcinoma animal model	22
Gelsevirine improves age-related and surgically induced osteoarthritis in mice by reducing STING availability and local inflammation	22
The resolvin D2 – GPR18 axis is expressed in human coronary atherosclerosis and transduces atheroprotection in apolipoprotein E deficient mice	22
β-patchoulene simultaneously ameliorated dextran sulfate sodium-induced colitis and secondary liver injury in mice via suppressing colonic leakage and flora imbalance	22
Targeting tyrosinase in hyperpigmentation: Current status, limitations and future promises	22
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction	22
A novel oral glucagon-like peptide 1 receptor agonist protects against diabetic cardiomyopathy via alleviating cardiac lipotoxicity induced mitochondria dysfunction	22
The sodium-glucose cotransporter-2 (SGLT2) inhibitors synergize with nitric oxide and prostacyclin to reduce human platelet activation	22
Peri-renal adipose inflammation contributes to renal dysfunction in a non-obese prediabetic rat model: Role of anti-diabetic drugs	22
MicroRNAs in diabetic nephropathy: From molecular mechanisms to new therapeutic targets of treatment	21
Interpersonal brain synchronization with instructor compensates for learner's sleep deprivation in interactive learning	21
P2X receptors in cancer growth and progression	21
Circulating tumor cells as a promising target for individualized drug susceptibility tests in cancer therapy	21
Plight of CORMs: The unreliability of four commercially available CO-releasing molecules, CORM-2, CORM-3, CORM-A1, and CORM-401, in studying CO biology	21
Development and application of novel electrophilic warheads in target identification and drug discovery	21
Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells	21
Pharmacological inhibition of DEAD-Box RNA Helicase 3 attenuates stress granule assembly	21
Ginsenoside CK induces apoptosis in triple-negative breast cancer cells by targeting glutamine metabolism	21
Glutathione S-transferases P1-mediated interleukin-6 in tumor-associated macrophages augments drug-resistance in MCF-7 breast cancer	21
Targeting the gasdermin D as a strategy for ischemic stroke therapy	21
Adenosine metabolism in the vascular system	21
The complex biology of aryl hydrocarbon receptor activation in cancer and beyond	21
Extracellular adenosine 5′-triphosphate in pulmonary disorders	21
Neuropeptide signalling systems – An underexplored target for venom drug discovery	21
MALAT1: A Promising Therapeutic Target for the Treatment of Metastatic Colorectal Cancer	20
Gliomas: Genetic alterations, mechanisms of metastasis, recurrence, drug resistance, and recent trends in molecular therapeutic options	20
Targeting lipophagy as a potential therapeutic strategy for nonalcoholic fatty liver disease	20
Prostaglandin E2 EP receptors in cardiovascular disease: An update	20
A multitarget semi-synthetic derivative of the flavonoid morin with improved in vitro vasorelaxant activity: Role of CaV1.2 and KCa1.1 channels	20
Prenatal dexamethasone exposure induces nonalcoholic fatty liver disease in male rat offspring via the miR-122/YY1/ACE2-MAS1 pathway	20
Comparative metabolomics reveals key pathways associated with the synergistic activity of polymyxin B and rifampicin combination against multidrug-resistant Acinetobacter baumannii	20
Targeting nucleolin by RNA G-quadruplex-forming motif	20
Suppression of adenosine A2a receptors alleviates bladder overactivity and hyperalgesia in cyclophosphamide-induced cystitis by inhibiting TRPV1	20
Characterization of human pregnane X receptor activators identified from a screening of the Tox21 compound library	20
The therapeutic triad of extracellular vesicles: As drug targets, as drugs, and as drug carriers	20
Trehalose protects against cisplatin-induced cochlear hair cell damage by activating TFEB-mediated autophagy	20
REV-ERBα agonist SR9009 suppresses IL-1β production in macrophages through BMAL1-dependent inhibition of inflammasome	20
Alterations in endothelial nitric oxide synthase activity and their relevance to blood pressure	20
Immunometabolic attributes and mitochondria-associated signaling of Tumor-Associated Macrophages in tumor microenvironment modulate cancer progression	20
Protective effect of the sphingosine-1 phosphate receptor agonist siponimod on disrupted blood brain barrier function	20
Nitric oxide deficiency is a primary driver of hypertension	20
Cardiac glycosides inhibit cancer through Na/K-ATPase-dependent cell death induction	19
Impact of alternative splicing on mechanisms of resistance to anticancer drugs	19
LncRNA-Malat1 down-regulates miR-211-5p expression to promote neuronal damage from cerebral ischemia reperfusion injury	19
TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer	19
Targeting Wnt/β-catenin signaling by microRNAs as a therapeutic approach in chemoresistant osteosarcoma	19
The mechanisms of interactions of psychotropic drugs with liver and brain cytochrome P450 and their significance for drug effect and drug-drug interactions	19
Involvement of NLRP3/Caspase-1/GSDMD-Dependent pyroptosis in BPA-Induced apoptosis of human neuroblastoma cells	19
A systems-approach to NAD+ restoration	19
FGFR3 phosphorylates EGFR to promote cisplatin-resistance in ovarian cancer	19
Obesity III: Obesogen assays: Limitations, strengths, and new directions	19
SIRT3 attenuates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome via autophagy	19
MiR-21-5p directly contributes to regulating eNOS expression in human artery endothelial cells under normoxia and hypoxia	19
Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A review	19
Lung cancer associated with combustion particles and fine particulate matter (PM2.5) - The roles of polycyclic aromatic hydrocarbons (PAHs) and the aryl hydrocarbon receptor (AhR)	19
Recognition of nucleolin through interaction with RNA G-quadruplex	19
Molecular and functional characterization of flavin-containing monooxygenases in pigs, dogs, and cats	19
Gold nanostructures as mediators of hyperthermia therapies in breast cancer	19
Scutellarin potentiates vancomycin against lethal pneumonia caused by methicillin-resistant Staphylococcus aureus through dual inhibition of sortase A and caseinolytic peptidase P	18
3-Deazaadenosine, an S-adenosylhomocysteine hydrolase inhibitor, attenuates lipopolysaccharide-induced inflammatory responses via inhibition of AP-1 and NF-κB signaling	18
A current overview of RhoA, RhoB, and RhoC functions in vascular biology and pathology	18
Cyclin-dependent kinase 1 as a potential target for lycorine against hepatocellular carcinoma	18
Early evolutionary history (from bacteria to hemichordata) of the omnipresent purinergic signalling: A tribute to Geoff Burnstock inquisitive mind	18
Valdecoxib improves lipid-induced skeletal muscle insulin resistance via simultaneous suppression of inflammation and endoplasmic reticulum stress	18
Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges	18